C onfusion persists regarding the severity of pain and disability associated with adult spinal deformity (ASD). Some reports indicate that ASD causes little disability other than back pain, whereas other reports indicate that ASD patients report greater functional limitations and worse quality of life compared with population norms. [1] [2] [3] [4] [5] The incidence of ASD is rising in conjunction with the aging U.S. population; therefore, medical providers and third-party payers are increasingly called upon to evaluate, treat, and authorize payment for the care of ASD patients. [6] [7] [8] [9] A growing body of research has emerged demonstrating that ASD is a heterogeneous disease composed of a variety of deformity types. [10] [11] [12] [13] [14] However, much of the historical literature characterized ASD as an adult version of adolescent idiopathic scoliosis (AIS); therefore, an incomplete understanding persists regarding the physiological reasons for disability associated with ASD because these studies only assessed scoliotic deformities rather than identifying that both coronal and sagittal plane deformities play an important role in the pathology that constitutes ASD. 4, 5 The Medical Outcomes Survey Short-Form 36 (Standard Form Version 2; SF-36) is a general health questionnaire that uses normative values for health assessment. Accordingly, SF-36 scores can be used to evaluate the health burden of a specific disease in relation to the general population and/or to other chronic diseases. [15] [16] [17] [18] [19] [20] Critical to interpreting SF-36 data and other health-related quality of life (HRQOL) measures is the concept of minimal clinically important difference (MCID), defined as the threshold value for a specific HRQOL score beyond which would be discernible by the patient as a clinically meaningful change. [21] [22] [23] [24] [25] [26] [27] Although the SF-36 has been used in spine research to evaluate outcomes, little data exist to quantify the health impact of different types and severities of spinal deformities that exist within ASD in comparison to other more familiar chronic diseases. 9, 28, 29 The purpose of this study was to (1) use the SF-36 questionnaire to compare the baseline physical and mental disability reported by a prospective cohort of consecutive symptomatic ASD (SASD) patients who have not had previous spine surgery to SF-36 scores reported by the U.S. general population and by patients with chronic diseases, (2) evaluate the impact that age has upon SASD by comparing generational SF-36 values for SASD patients to U.S. generational norms, and (3) evaluate the impact that specific types of spinal deformities have upon SASD patients in comparison to other chronic diseases.
MATERIALS AND METHODS
Data used for this study were obtained from a multicenter, prospective, longitudinal database (the database) consisting of consecutively enrolled ASD patients. Eleven participating sites located in the United States contributed patients to the database. Institutional review board (IRB) approval for this study was obtained at all participating centers before enrolling SASD patients into the database. Database inclusion criteria are age more than 18 years and minimum 1 of the following: scoliosis more than 20 degrees, sagittal vertical axis more than 5 cm (SVA; distance from C7 plumb line to the posterior, superior corner of S1), pelvic tilt more than 25 degrees (PT; angle between a vertical line and the line through the mid-point of the sacral plate to femoral heads axis), and/or thoracic kyphosis more than 60 degrees (TK; Cobb angle measured from superior endplate of T4 to inferior endplate of T12), as previously described. 30, 31 Exclusion criteria for database enrollment include spinal deformities associated with autoimmune, posttraumatic, neoplastic, neuromuscular, syndromic, and/or infectious disorders. An additional exclusion criterion for the current study was previous spine surgery.
All radiographic analyses of the spinal axis were performed using 36 00 full-length films that visualized from the cervical spine to the pelvis. Patients were instructed to assume a free-standing posture, with elbows flexed at approximately 45 degrees and fingertips on the clavicles. 32, 33 Antero-posterior (AP) and lateral films were obtained and sagittal and frontal spino-pelvic parameters were assessed using Spineview1 (Laboratory of Biomechanics, Paris, France). 34, 35 All demographic, radiographic, and SF-36 PCS and MCS values were obtained upon patient enrollment into the database, before treatment prescribed by the enrolling physician. All SF-36 data were reported as norm-based scores (NBS) with standard deviations (SDs 19 Recommended MCID values for SF-36 are between 2 and 3 NBS points for the PCS and 3 NBS points for the MCS. 19 For consistency and to avoid overestimating the impact of SASD and other disease states, the MCID value was set at 3 NBS points for both the PCS and MCS, as previously recommended. 19 SASD patients were divided into age generational cohorts as recommended by the User's Manual for the SF-36v2 Health Survey, Second Edition. 19 Type and severity of spinal deformity was characterized as primarily scoliosis (patients with scoliosis !20 degrees and SVA <5 cm), primarily sagittal (SVA !5 cm and scoliosis <20 degrees), combined scoliosis, and sagittal deformities (scoliosis !20 degrees and SVA !5 cm), as previously recommended. 36, 37 The type of scoliosis was defined according to the apex of the scoliosis including thoracic (apex T2-T11-12 disc space), thoracolumbar (apex T12-L1 vertebra), or lumbar spine (apex L1-2 disc space-L4), as previously recommended. 13, 38 Severity of the sagittal deformity was quantified according to the magnitude of the SVA (<5, !5, !10 cm), as previously recommended. 36, 37, 39 
Statistical Methods
Statistical analysis was performed using Stata 12.1 (StataCorp, College Station, TX). Analysis of ASD HRQOL values compared with U.S. population norms groups was performed using 2-tailed t tests, and analysis across age groups was performed using analysis of variance (ANOVA). Linear regression analysis was used to assess the impact of radiographic measures of deformity on the deviation from population norms. P values less than 0.05 were considered statistically significant.
RESULTS
Between 2008 and 2011, 497 consecutive SASD patients met inclusion criteria and were evaluated for this study. Mean age of all SASD patients was 50.4 years (SD ¼ 16.9), mean scoliosis was 45.3 degrees (SD ¼ 18.3), and mean SVA was 1.99 cm (SD ¼ 58.1; Table 1 and Fig. 1A-D) . Mean PCS for all SASD patients was 40.9 (SD ¼ 11.2) and mean MCS was 49.4 (SD ¼ 11.3; Table 1 and Fig. 1E ). Compared with the U.S. general population, the mean PCS for all SASD patients was 9 NBS points lower than the U.S. general population, and more than 3 NBS points below the 25th percentile for U.S. general population, whereas the MCS value for the total SASD cohort was similar to U.S. general population norms (Table 2) . Generational PCS values for all SASD age groups were lower than respective U.S. generational values and were more than 3 NBS points below the 25th percentile for all respective U.S. generational norms for all age groups except for the youngest age group (P < 0.05), while MCS values for the each SASD generation were similar to U.S. generational norms ( Table 2) . SASD patients demonstrated a more rapid decline in generational PCS values than the U.S. general population, as the reduction in average SASD PCS across successive generations was greater than that of the U.S. successive generational decline (Table 2 ; P < 0.05). Analysis of a subset of SASD patients with no other reported comorbidities compared with U.S. total and generational norms demonstrated that the mean generational PCS for SASD patients with no other reported comorbidities was more than 3 NBS points lower than the respective U.S. generational norm for all generations except for the youngest and oldest age groups (P < 0.05; Table 3 ).
Comparison of the mean PCS score for all SASD patients to PCS scores for chronic diseases demonstrated that the mean SASD PCS was more than 3 NBS points worse than chronic back pain and hypertension (P < 0.05), and was similar cancer, diabetes, and heart disease ( Table 4) . 19 Analysis of SASD according to the type and severity of spinal deformity demonstrated that patients with primarily scoliosis deformities in the lumbar spine (scoliosis >20 degrees, SVA <5 cm) had worse PCS scores than patients with primarily scoliosis deformities in the thoracic spine (PCS ¼ 36.7 vs 45.5, respectively; P < 0.05), and patients with primarily sagittal deformities (scoliosis <20 degrees, SVA >5 cm) had worse PCS scores than patients with primarily scoliosis deformities (PCS ¼ 32.4 vs 43.8, respectively; P < 0.05; Figure 2 ). Patients with combined lumbar scoliosis and severe sagittal deformity (SVA >10 cm) demonstrated the worst PCS of all patients reported in this study (PCS ¼ 24.7; P < 0.05). Comparison of the different deformity types to reported values for chronic diseases demonstrated that SASD patients with primarily thoracic scoliosis deformities had similar PCS scores as reported values for patients with chronic back pain (45.5 vs 45.7, respectively; Figure 3A , B, and Figure 2 ). 19 Patients with primarily lumbar scoliosis deformities reported similar PCS scores as patients with osteoarthritis and chronic heart disease (36.7 vs 38.6 vs 38.9, respectively) and patients with primarily sagittal deformities (scoliosis <20 degrees, SVA >5 cm) reported similar PCS scores as patients with osteoarthritis and rheumatoid arthritis functioning below the 25th percentile for the disease group (30.4 vs 30.1 vs 31.7, respectively). 19 Patients with primarily severe sagittal deformity (SVA >10 cm) had similar PCS scores as patients with chronic lung disease that function below the 25th percentile for the disease group (28.5 vs 30.1, respectively; Figure 4A , B). Patients with combined lumbar scoliosis and severe sagittal deformities (SVA >10 cm) reported severe disability (PCS ¼ 24.7) and had worse PCS scores than values reported for patients with limited vision and limited function of the arms and legs ( Figure 5A , B).
19 Table 5 summarizes the results of ordinary least squares (OLS) regression analysis specifying the deviation in a patient's PCS from United States generational norms as a function of body mass index (BMI), Charlson comorbidity index (CCI) 40 , gender, scoliosis, PT, and SVA. BMI, CCI, gender, PT, and SVA all demonstrated a significantly negative effect on the deviation in PCS from U.S. generational norms. Specifically, a 1-mm increase in SVA lead to a significant reduction in PCS of 0.06 points compared with the relevant U.S. generational norm. Similarly, a 1-degree increase in PT lead to a reduction in PCS of 0.12 points compared with the relevant U.S. generational norm. Separate regressions for each age group revealed that PT had the largest negative effect (À0.51, P ¼ 0.004) on PCS relative to U.S. norms for patients aged 45 to 54 years, with a smaller but significant effect (À0.11) for patients aged 55 to 64 years, while SVA had the largest negative effect (À0.10, P ¼ 0.001) on PCS relative to U.S. norms for patients aged 55 to 64 years, with a smaller but significant effect (À0.06) for patients aged 65 to 74 years. 
DISCUSSION
There is an increasing awareness in the spine community of the types of spinal deformities and radiographic parameters most associated with pain and disability; however, the greater medical community remains uneducated regarding the reasons for disability associated with SASD. 30,41 -43 We performed a multicenter, prospective evaluation of SF-36 scores from a large cohort of consecutive SASD patients who had no history of previous spine surgery and found that the SASD population demonstrated substantial disability compared with the U.S. population and demonstrated a greater generational worsening in physical function as measured by SF-36 PCS scores than the U.S. general population. Importantly, this study reinforces that SASD is a heterogeneous disease, composed of different deformity types, some of which are more disabling than others. In an attempt to draw analogies to alternate diseases that are more familiar to health care providers, we compared the SF-36 PCS and MCS values for SASD patients with values reported for other chronic diseases, and found that although patients with isolated thoracic scoliosis deformities reported similar disability as patients with chronic back pain, SASD patients with severe sagittal malalignment (SVA >10 cm), and patients with lumbar scoliosis combined with sagittal malalignment reported extreme disability with SF-36 PCS scores worse than patients who have limited use of their arms and legs.
A substantial amount of research has been devoted toward understanding if and why ASD patients are disabled. In a seminal, and often referenced, series of investigations, Weinstein et al 4, 5 evaluated the long-term outcome of untreated adult idiopathic scoliosis [termed late onset idiopathic scoliosis (LIS) in the studies]. The authors reported that at 50-year follow-up, patients with untreated LIS reported no more back pain than the general population. 4 We hope that our findings expand those reported by Weinstein et al, 4, 5 because this study evaluated the health impact that coronal and sagittal plane deformities have upon SASD patients, whereas the reports by Weinstein et al 4, 5 did not evaluate the sagittal plane. Consistent with the data reported by Weinstein et al, 4, 5 the SASD patients with isolated thoracic scoliosis in our study population reported the least amount of disability, while patients with sagittal malalignment and patients with combined deformities that included coronal and sagittal malalignment reported the most disability. These findings are further explained by the ordinary least squares regression analysis, which demonstrated that sagittal malalignment (as measured by increased SVA) and sagittal spinopelvic malalignment (as measured by increased PT) had the greatest negative impact on ASD generational deviation from U.S. SF-36 PCS normative values, while maximal scoliosis had a little relative impact.
The SF-36 general health questionnaire is commonly used to evaluate outcomes following treatment for ASD. However, the SF-36 questionnaire can also be used to compare ASD with other diseases. Schwab et al 29 compared SF-36 scores for adults with scoliosis with patients with hypertension and low back pain. Pellise et al 44 compared SF-36 scores from ASD patients with published scores of patients with self-reported arthritis, lung disease, diabetes, and heart failure. Similar to our findings, the authors reported that ASD patients had worse SF-36 PCS scores than patients with the measured chronic diseases. Our data expand upon these findings, as we evaluated different age groups and specific spine deformity types and found that (1) the negative effect that SASD imparts upon physical health impacts all age generations, (2) the physical detriment associated with SASD worsens with age beyond what is expected from aging, and (3) chronic disease analogies can be created according to the disability associated the specific type and the severity of the spinal deformity.
Limitations of this study include the use of previously reported, standardized SF-36 data for U.S. population and chronic diseases. The SASD cohort evaluated for this study was a prospective, consecutively enrolled patient population; however, the SF-36 values for the ASD cohort were compared with previously reported normative SF-36 values. A benefit of the SF-36 questionnaire lies in the ability to quantify the impact on different disease states on physical and mental health and provide a standardized value for comparison to other disease states; however, it is possible that data collected on a prospective, consecutive cohort of control patients could generate different values. In addition, the SF-36 values for the ASD population reported in this study were obtained from patients presenting to physicians for evaluation of their deformity; therefore, a selection bias may exist, as it is possible that the patients evaluated in this study are the most symptomatic and not representative of all ASD patients, which is why the cohort was labeled the SASD. Although our data consist of a large cohort of SASD patients who reported varying disabilities that was found to correspond to the type and severity of the specific spinal deformity, the authors acknowledge that it is possible that some ASD patients may be asymptomatic and that these data do not supplant a larger population-based study. It is also important to note that this study did not evaluate the effectiveness of treatments for ASD; therefore, the authors cannot comment on efficacy of different treatments for ASD. The goal of this study was to quantify the baseline impact that different forms of SASD have upon physical and mental health. An evaluation of the efficacy of operative and nonoperative treatment for ASD is currently underway, and will be reported as the dataset matures.
In conclusion, our findings demonstrate that SASD patients can be markedly disabled compared with the U.S. general population, with a similar impact of more recognized chronic diseases. The effect of SASD demonstrated a greater reported impact on physical health than can be attributed solely to aging. Importantly, SASD patients with different types of spinal deformities have varying disabilities and, accordingly, we have provided analogous disease comparisons that correspond to the reported physical impact that can facilitate an understanding of the patient-reported physical limitations. We hope that these data will assist physicians and health care providers to more effectively evaluate patients with SASD and support that SASD warrants similar health policy attention as other chronic diseases. 
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Key Points
Mean SF-36 PCS for SASD patients was lower than U.S. total population. SASD disability increases with age as SASD generational decline in SF-36 PCS worsened more rapidly than U.S. age generational norms. The mean SF-36 PCS values for all SASD patients was similar to values reported by patients with diabetes, heart disease, and rheumatoid arthritis. The severity of the disease burden caused by SASD varies according to the type and severity of the deformity, as patients with more severe forms of SASD reported similar physical limitations and health impact as patients with limited use of arms and legs.
